Trends in COX-2 Inhibitor Research
Maynard J. Howardell
[135] Csiki I, Dang T, Gonzalez A. Cyclooxygenase-2 (COX-2) inhibition +
docetaxel (Txt). in recurrent non-small cell lung cancer (NSCLC): preliminary
results of a phase II trial (THO-0054). Proc Am Soc Clin Oncol 2002:21:297a,
abstract ...